United States · FDA National Drug Code directory

Endopar F

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 44911-0308_87d22a70-0356-477c-9085-9a7d351bbfc8
Product NDC: 44911-0308
Form: LIQUID
Composition / generic term: Cimicifuga Racemosa, Fucus Vesiculosus, Oophorinum (Suis), Hypophysis Suis, Thyroidinum (Suis), Graphites, Lachesis Mutus, Natrum Muriaticum, Pulsatilla (Pratensis), Sepia
Labeler: Energique, Inc.
Marketing category: UNAPPROVED HOMEOPATHIC
Marketing start / end (source format): 20151130
Source listing expiry: 20261231

Source-listed ingredients

BLACK COHOSH — 3 [hp_X]/mL
FUCUS VESICULOSUS — 3 [hp_X]/mL
SUS SCROFA OVARY — 6 [hp_X]/mL
SUS SCROFA PITUITARY GLAND — 6 [hp_X]/mL
THYROID — 6 [hp_X]/mL
GRAPHITE — 12 [hp_X]/mL
LACHESIS MUTA VENOM — 12 [hp_X]/mL
SODIUM CHLORIDE — 12 [hp_X]/mL
PULSATILLA PRATENSIS WHOLE — 12 [hp_X]/mL
SEPIA OFFICINALIS JUICE — 12 [hp_X]/mL

These values do not establish equivalence or a dose recommendation.

Packages

30 mL in 1 BOTTLE, DROPPER (44911-0308-1) · 44911-0308-1

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →